The Q1 financials are backward-looking and reflect a transition quarter — the stock will trade on the post-quarter catalysts: the Yorkville $100M facility provides near-term funding, and the ULVAC purchase orders de-risk the capacity expansion timeline to 10,000 tons by November 2026. Monitor for additional commercial offtake agreements and progress on the U.S. industrial campus buildout. The DFARS deadline creates a hard catalyst in January 2027.
Price Chart
Executive Summary
EM&T reported Q1 2026 results reflecting its first quarter as a public company post-business combination. Revenue was $1.9M with a GAAP net loss of $440.3M ($0.72/share), driven by $425.2M in non-cash fair value charges on pre-combination instruments that were settled at closing. Adjusted net loss (non-GAAP) was $15.1M ($0.02/share). The quarter's significance is overshadowed by post-quarter-end events: a $100M Yorkville convertible debenture facility and binding purchase orders for 13 ULVAC magnet production machines, positioning EM&T to scale annual capacity to ~10,000 metric tons by November 2026 ahead of the DFARS deadline.
Key Financial Metrics
Key Facts
- Q1 2026 revenue of $1.9M vs $0 in Q1 2025 (first quarter consolidating operating subsidiaries post-business combination)
- GAAP net loss of $440.3M ($0.72/share) includes $425.2M non-cash fair value charges on pre-combination derivatives settled at closing
- Adjusted net loss (non-GAAP) of $15.1M ($0.02/share) vs $2.5M ($0.01/share) in Q1 2025
- Cash burn of $5.6M from operations; cash balance declined to $5.4M from $11.7M at year-end 2025
- Post-quarter: $100M convertible debenture facility with Yorkville Advisors Global (May 7, 2026)
- Post-quarter: Binding purchase orders for 13 ULVAC sintered magnet production machines, targeting ~10,000 metric tons annual capacity by November 2026 (May 13, 2026)
- ULVAC order represents more than a full year of ULVAC's planned global Western output
- Company benefits from U.S. policy tailwinds: Section 232 Proclamation (Jan 2026), Project Vault $12B critical minerals reserve (Feb 2026), DFARS deadline Jan 1, 2027 restricting Chinese-origin rare earth magnets in defense systems
Financial Impact
Q1 revenue $1.9M, GAAP net loss $440.3M, adjusted net loss $15.1M, cash burn $5.6M; post-quarter $100M convertible debenture facility and ULVAC equipment orders represent transformative capacity expansion
Risk Factors
- Yorkville convertible debenture carries conversion mechanics that could create dilution overhang
- ULVAC machine delivery and commissioning by November 2026 is an aggressive timeline with execution risk
- Cash balance of $5.4M is low; company will need to draw on the Yorkville facility or raise additional capital to fund operations and capex
- Revenue of $1.9M is minimal relative to the planned capacity scale; commercial offtake agreements are not yet announced
- Stockholders' deficit of $24.6M and total deficit of $10.6M indicate balance sheet stress
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-060343 |
| Document: ea0291985-8k_evolution.htm | 0001213900-26-060343 |
| Document: 0001213900-26-060343-index-headers.html | 0001213900-26-060343 |
| Document: 0001213900-26-060343-index.html | 0001213900-26-060343 |
| Document: 0001213900-26-060343.txt | 0001213900-26-060343 |
| 8-K Data (Synthetic) | 0001213900-26-060343 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | 8-K | $1.54 | awaiting T+20 | — | $1.43 (−7.14%) |
Oct 15, 2026 12d ago | Press Release | $1.54 | awaiting T+20 | — | $1.43 (−7.14%) |
Oct 14, 2026 13d ago | 8-K | $1.50 | awaiting T+20 | — | $1.43 (−4.67%) |
Oct 13, 2026 14d ago | EFFECT | $1.43 | awaiting T+20 | — | $1.43 (−0.35%) |
Oct 9, 2026 18d ago | 8-K | $1.64 | awaiting T+20 | — | $1.43 (−12.80%) |
Oct 8, 2026 19d ago | 3 | $1.64 | awaiting T+20 | — | $1.43 (−12.80%) |
Oct 6, 2026 21d ago | Press Release | $1.92 | awaiting T+20 | — | $1.43 (−25.52%) |
Oct 6, 2026 21d ago | 8-K | $1.92 | awaiting T+20 | — | $1.43 (−25.52%) |
Oct 6, 2026 21d ago | EFFECT | $1.92 | awaiting T+20 | — | $1.43 (+25.52%) |
Oct 5, 2026 22d ago | S-1 | $1.92 | awaiting T+20 | — | $1.43 (+25.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers